Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Jushen Pharmaceutical Co., Ltd. is a pharmaceutical company based in Haikou, Hainan, China, operating as a subsidiary of Jushen Pharmaceutical Group. The company specializes in the research, development, and manufacturing of traditional Chinese medicines (specifically Hainan's local Li and Southern medicines), chemical drugs, and health products. Its core product portfolio includes Shema Oral Liquid (射麻口服液) for respiratory conditions, Callicarpa nudiflora capsules (裸花紫珠胶囊) for anti-inflammatory and hemostatic indications, and Acetaminophen and Dihydrocodeine tablets (氨酚双氢可待因片) for pain management. Hainan Jushen operates a modern manufacturing base in the Haikou National High-Tech Industrial Development Zone, featuring multiple GMP-certified production lines for oral liquids, capsules, tablets, and granules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Jushen Pharmaceutical.